Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-04

Clinical Trial Update: IM Olanzapine Versus Haloperidol or Midazolam [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intramuscular olanzapine to haloperidol or midazolam for acute agitation; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • Midazolam (Midazolam)
  • olanzapine (olanzapine)

Snippet

Sponsor: The University of Hong Kong | Conditions: Acute Agitation, Behavioural Emergency | Phase 4 | Status: TERMINATED